Money Talk

Additional clinical trial data needed for US approval of Covaxin: Bharat Biotech

Additional clinical trial data needed for US approval of Covaxin: Bharat Biotech Bharat Biotech didn#39;t clarify the nature of the clinical trial – whether it is a local bridging trial or a Phase -3 trial sought by the USFDA. The vaccine maker said Covaxin has received emergency use authorisation’s from 14 countries with more than 50 countries in the process.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s